Barinthus Biotherapeutics (BRNS) Stock Price & Financial Analysis
Barinthus Biotherapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Barinthus Biotherapeutics
What is the current stock price for BRNS?
As of the latest trading session, BRNS stock trades at $0.60. The 52-week range is $0.51–$2.92, with a day range of $0.54–$0.62.
What is the P/E ratio for BRNS?
The P/E ratio (Price-to-Earnings) for BRNS is shown in the Key Statistics section. This valuation metric helps compare Barinthus Biotherapeutics plc to industry peers.
Does BRNS pay dividends?
Barinthus Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for BRNS?
Analyst ratings and recommendations for BRNS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of BRNS?
Barinthus Biotherapeutics's market capitalization is $24.4M, classifying it as a micro-cap company. Barinthus Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.